Preclinical and Clinical Researchers play a critical role in the drug development process, ensuring that new treatments are both effective and safe before they reach the market. Preclinical researchers conduct studies in laboratories and animal models to gather the initial data on a drug’s safety, efficacy, and pharmacokinetics. These early-stage studies help identify the potential risks and benefits of a drug, as well as the optimal dosage and administration routes. Preclinical research serves as the foundation for clinical trials, where drugs are tested in human subjects for the first time. Preclinical studies are essential for laying the groundwork for clinical research, ensuring that only the most promising candidates advance to human testing.
After passing preclinical testing, clinical researchers take over to lead trials in human volunteers and patients. Clinical researchers are responsible for designing and conducting clinical trials, which are divided into phases to evaluate the drug’s safety, effectiveness, and long-term impacts. Clinical researchers ensure that all trials are conducted ethically and in compliance with regulatory guidelines, gathering critical data to support drug approval by regulatory agencies. By analyzing data from clinical trials, these researchers provide vital information that helps determine whether a drug can be approved for widespread use. As the demand for more personalized and targeted therapies grows, preclinical and clinical researchers are essential in transforming scientific discoveries into real-world treatments that benefit patients globally.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia